Key statistics
On Friday, Evolus Inc (0K16:LSE) closed at 13.55, -23.93% below its 52-week high of 17.81, set on Oct 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 13.55 |
Low | 13.55 |
Bid | -- |
Offer | -- |
Previous close | 14.92 |
Average volume | 1.15k |
---|---|
Shares outstanding | 63.32m |
Free float | 49.78m |
P/E (TTM) | -- |
Market cap | 866.24m USD |
EPS (TTM) | -0.9141 USD |
Data delayed at least 20 minutes, as of Nov 08 2024 18:36 GMT.
More ▼
Press releases
- Evolus Reports Third Quarter 2024 Results
- Evolus to Participate in Stifel 2024 Healthcare Conference
- Evolus Announces EU Approval of Estyme® Injectable Hyaluronic Acid Gels Under New Medical Device Regulation
- Evolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled Consumers
- Evolus to Report Third Quarter Financial Results on November 6, 2024
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024
More ▼